Home Newsfeeds Republic Bancorp Q2 EPS $1.20 Up From $1.16 YoY

Republic Bancorp Q2 EPS $1.20 Up From $1.16 YoY

Republic Bancorp (NASDAQ:RBCAA) reported quarterly earnings of $1.20 per share. This is a 3.45 percent increase over earnings of $1.16 per share from the same period last year.

byBenzinga Newsdesk

July 22, 2022

1 minute read

Republic Bancorp (NASDAQ:RBCAA) reported quarterly earnings of $1.20 per share. This is a 3.45 percent increase over earnings of $1.16 per share from the same period last year.

Earnings

Verint Systems: Q3 Earnings Insights

By Benzinga Insights

December 6, 5:10 PM

Verint Systems (NASDAQ:VRNT) reported its Q3 earnings results on Wednesday, December 6, 2023 at 04:05 PM. Here’s what…

VRNT

Stork, A Fluor company, Awarded 5-Year Asset Integrity Contract On The United Kingdom Continental Shelf; No Financial Terms Disclosed

By Happy Mohamed

May 24, 4:48 PM

Fluor Corporation (NYSE:FLR) announced today that Stork, a Fluor company, has been awarded a five-year contract, plus five one-year extension options with London-based Harbour Energy. The contract extends

FLR

Avant & IM Cannabis Team Up To Bring New Medical Marijuana Products To Isreal

By Jelena Martinovic

October 12, 9:30 AM

Avant Brands Inc. (TSX: AVNT) (OTC-QX: AVTBF) (FRA: 1BU0) and IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) jointly announced on Wednesday the signing of an international trademark licensing agreement granting IMC the exclusive right to launch the BLKMKT brand in the Israeli medical

AVTBF

Mirum Pharmaceuticals Announces New PDUFA Date Of March 13, 2024 For LIVMARLI For The Treatment Of Cholestatic Pruritus In Progressive Familial Intrahepatic Cholestasis

By Benzinga Newsdesk

October 17, 4:37 PM

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) today announced that the U.S. Food and Drug Administration (FDA) has extended the review of the Supplemental New Drug Application (sNDA) for LIVMARLI® (maralixibat) oral

MIRM

Republic Bancorp Q2 EPS $1.20 Up From $1.16 YoY

Related Posts

Verint Systems: Q3 Earnings Insights

Stork, A Fluor company, Awarded 5-Year Asset Integrity Contract On The United Kingdom Continental Shelf; No Financial Terms Disclosed

Avant & IM Cannabis Team Up To Bring New Medical Marijuana Products To Isreal

Mirum Pharmaceuticals Announces New PDUFA Date Of March 13, 2024 For LIVMARLI For The Treatment Of Cholestatic Pruritus In Progressive Familial Intrahepatic Cholestasis